Class Action Lawsuit Filed Against Neumora Therapeutics Over Securities Violations

The Schall Law Firm, a national firm focused on shareholder rights, has initiated a class action lawsuit against Neumora Therapeutics, Inc. (“Neumora” or “the Company”) NMRA for breaching federal securities laws.

Why Investors Should Act Now

Individuals who acquired the Company’s securities according to its Offering Documents during the initial public offering (“IPO”) on September 15, 2023, are encouraged to reach out to the firm by April 7, 2025.

Shareholders who experienced financial losses are invited to participate in the case.

Contact Information for Legal Representation

For more details about your rights, contact Brian Schall of the Schall Law Firm at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, or call 310-301-3335. You can also visit our website at www.schallfirm.com or email us at bschall@schallfirm.com.

Important Details About the Class Action Status

Please note that the class has not yet been certified. Until certification occurs, you are not represented by an attorney. If you decide to do nothing, you will remain an absent class member.

Claims of Misleading Statements by Neumora

The complaint alleges that Neumora made false and misleading statements to the public. The Company defended its Phase Three Program on Navacaprant by modifying BlackThorn’s Phase Two Trial to include patients with moderate to severe major depressive disorder (“MDD”). However, critics argue that the Phase Two Trials did not provide sufficient data, particularly concerning population size and gender ratios, to reliably predict outcomes for its KOASTAL-1 study. As a result, the Company’s public statements during this period were deemed false and misleading, leading to investor damages once the facts became known.

Join the Case and Regain Your Losses

Investors are encouraged to join the class action to seek recovery for their losses.

About the Schall Law Firm

The Schall Law Firm serves clients worldwide and specializes in securities class-action lawsuits and shareholder rights litigation.

This announcement may qualify as Attorney Advertising in certain jurisdictions under applicable laws and ethical standards.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250212935146/en/

The Schall Law Firm
Brian Schall, Esq.
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com